Nitric oxide (NO•), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase

Biochemical Pharmacology

Volumn 51, Issue 12, 1996, Pages 1593-1600

  Dierks, Elizabeth A ^a   Burstyn, Judith N ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Endothelium derived relaxing factor (EDRF); Nitric oxide; Nitrosonium; Nitroxyl; Soluble guanylyl cyclase

Indexed keywords

GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; ORGANIC SOLVENT; REAGENT; ACID; CATION; INORGANIC SALT; OXYGEN;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REACTION ANALYSIS; METABOLISM; OXIDATION REDUCTION REACTION;

ACIDS; CATIONS; GUANYLATE CYCLASE; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN; SALTS;

EID: 0029664587     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00078-0     Document Type: Article

References (51)

1. Ignarro LJ, Heme-dependent activation of soluble guanylate cyclase by nitric oxide: Regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol 26: 63-76, 1989.
2. Wolin MS, Wood KS and Ignarro LJ, Guanylate cyclase from bovine lung: A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosylheme. J Biol Chem 257: 13312-13320, 1982.
3. Ignarro LJ, Degnan JN, Baricos WH, Kadowitz PJ and Wolin MS, Activation of purified guanylate cyclase by nitric oxide requires heme: Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochem Biophys Acta 718: 49-59, 1982.
4. Garbers DL, Purification of soluble guanylate cyclase from rat lung. J Biol Chem 254: 240-243, 1979.
5. Kamisaki Y, Saheki S, Nakane M, Palmieri JA, Kuno T, Chang BY, Waldman SA and Murad F, Soluble guanylate cyclase from rat lung exists as a heterodimer. J Biol Chem 261: 7236-7241, 1986.
6. Gerzer R, Böhme E, Hofmann F and Schultz G, Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132: 71-74, 1981.
7. Ignarro LJ, Adams JB, Horwitz PM and Wood KS, Activation of soluble guanylyl cyclase by NO-hemoproteins involves NO-heme exchange. J Biol Chem 261: 4997-5002, 1986.
8. Stone JR and Marletta MA, Soluble guanylyl cyclase from bovine lung: Activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33: 5636-5640, 1994.
9. Burstyn JN, Yu AE, Dierks EA, Hawkins BK and Dawson JH, Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): Characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme. Biochemistry 34: 5896-5903, 1995.
10. Yu AE, Hu S, Spiro TG and Burstyn JN, Resonance Raman spectroscopy of soluble guanylyl cyclase reveals displacement of distal and proximal heme ligands by NO. J Am Chem Soc 116: 4117-4118, 1994.
11. Stone JR, Sands RH, Dunham WR and Marietta MA, Electron paramagnetic resonance evidence for the formation of a pentacoordinate nitrosyl-heme complex on soluble guanylate cyclase. Biochem Biophys Res Commun 207: 572-577, 1995.
12. Mülsch A, Vanin A, Mordvintcev P, Hauschildt S and Busse R, NO accounts completely for the oxygenated species generated by enzymic L-arginine oxygenation. Biochem J 288: 597-603, 1992.
13. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ and Loscalzo J, S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444-448, 1992.
14. Marletta MA, Nitric oxide: Biosynthesis and biological significance. Trends Biol Sci 14: 488-492, 1989.
15. Leone AM, Palmer RMJ, Knowles RG, Francis PL, Ashton DS and Moncada S, Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J Biol Chem 266: 23790-23795, 1991.
16. Fukuto JM, Wallace GC, Hszieh R and Chaudhuri G, Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation. Biochem Pharmacol 43: 607-613, 1992.
17. G-hydroxy-L-arginine by nitric oxide synthase. Biochemistry 34: 1930-1941, 1995.
18. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL and Wiseman J, N-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 266: 6259-6263, 1991.
19. Wallace GC, Gulati P and Fukuto JM, N-Hydroxy-L-arginine: A novel arginine analog capable of causing vasorelaxation in bovine intrapulmonary artery. Biochem Biophys Res Commun 176: 528-534, 1991.
20. Zembowicz A, Hecker M, Macarthur H, Sessa WC and Vane JR, Nitric oxide and another potent vasodilator are formed from N-hydroxy-L-arginine by cultured endothelial cells. Proc Natl Acad Sci USA 88: 11172-11176, 1991.
21. Long CJ, Shikano K and Berkowitz BA, Anion exchange resins discriminate between nitric oxide and EDRF. Eur J Pharmacol 142: 317-318, 1987.
22. Greenberg SS, Wilcox DE and Rubanyi GM, Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy. Circ Res 67: 1446-1452, 1990.
23. Fukuto JM, Chiang K, Hszieh R, Wong P and Chaudhuri G, The pharmacological activity of nitroxyl: A potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther 263: 546-551, 1992.
24. -) using L-cysteine. Biochem Biophys Res Commun 201: 54-62, 1994.
25. Stamler JS, Singel DJ and Loscalzo J, Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
26. Feelisch M, te Poel M, Zamora R, Deussen A and Moncada S, Understanding the controversy over the identity of EDRF. Nature 368: 62-65, 1994.
27. Kim TD and Burstyn JN, Identification and partial purification of an endogenous inhibitor of soluble guanylyl cyclase from bovine lung. J Biol Chem 269, 15540-15545, 1994.
28. Oser BL (Ed.), Hawk's Physiological Chemistry, 14th Edn, pp. 178-181. McGraw-Hill, New York, 1965.
29. McCleverty JA, Reactions of nitric oxide coordinated to transition metals. Chem Rev 79: 53-76, 1979.
30. Swinehart JH, The nitroprusside ion. Coordin Chem Rev 2: 385-402, 1967.
31. 2. Proc Natl Acad Sci USA 69: 3534-3536, 1972.
32. Bottomley F, Electrophilic behavior of coordinated nitric oxide. Ace Chem Res 11: 158-162, 1978.
33. Glidewell C and Johnson IL, Definitive identification of the primary reduction product of the nitroprusside ion, pentacyanonitrosylferrate(2-), in aqueous solution. Inorg Chim Acta 132: 145-147, 1987.
34. Bonner FT and Ravid B, Thermal decomposition of oxyhyponitrite (sodium trioxodinate(II)) in aqueous solution. Inorg Chem 14: 558-563, 1975.
35. 15NO that trioxodinitrite(II) decomposes into nitrosyl hydride and nitrite in neutral aqueous solution. Inorg Chem 24: 4285-4288, 1985.
36. Doyle MP, Mahapatro SN, Broene RD and Guy JK, Oxidation and reduction of hemoproteins by trioxodinitrite(II). The role of nitrosyl hydride and nitrite. J Am Chem Soc 110: 593-599, 1988.
37. 15N NMR study of N-hydroxybenzenesulfonamide decomposition: An HNO source reaction. Inorg Chem 31: 2514-2519, 1992.
38. Bonner FT, Degani H and Akhtar MJ, Nitrogen-15 magnetic resonance spectroscopy of trioxodinitrate: N-Protonation of an oxoanion. J Am Chem Soc 103: 3739-3742, 1981.
39. Ignarro LJ and Gruetter CA, Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrite and sodium nitrite. Biochim Biophys Acta 631: 221-231, 1980.
40. Ignarro LJ, Ballot B and Wood KS, Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem 259: 6201-6207, 1984.
41. Cotton FA and Wilkinson G, Advanced Inorganic Chemistry, 5th Edn. John Wiley, New York, 1988.
42. Palmer RMJ, Ferrige AG and Moncada S, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
43. Ignarro LJ, Byrns RE, Buga GM and Wood KS, Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61: 866-879, 1987.
44. Waldman SA and Murad F, Cyclic GMP synthesis and function. Pharmacol Rev 39: 163-196, 1987.
45. Butler AR and Williams DLH, The physiological role of nitric oxide. Chem Soc Rev 22: 233-241, 1993.
46. Kharitonov VG, Sundquist AR and Sharma VS, Kinetics of nitric oxide autoxidation in aqueous solution. J Biol Chem 269: 5881-5883, 1994.
47. Fukuto JM, Hszieh R, Gulati P, Chiang KT and Nagasawa HT, N,O-Diacylated-N-hydroxyarylsulfonamides: Nitroxyl precursors with potent smooth muscle relaxant properties. Biochem Biophys Res Commun 187: 1367-1373, 1992.
48. Murphy ME and Sies H, Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci USA 88: 10860-10864, 1991.
49. 2 to form peroxonitrite. Inorg Chem 25: 2676-2677, 1986.
50. Bazylinski DA and Hollocher TC, Metmyoglobin and methemoglobin as efficient traps for nitrosyl hydride (nitroxyl) in neutral aqueous solution. J Am Chem Soc 107: 7982-7986, 1985.
51. Bazylinski DA, Goretski J and Hollocher TC, On the reaction of trioxodinitrite(II) with hemoglobin and myoglobin. J Am Chem Soc 107: 7986-7978, 1985.